Client News

Destiny Pharma announces start of a new XF-73 research programme

Newron extends Senior Management team and strengthens commitment to ESG

Element drives global life science strategy with appointment of industry expert Dr. Elisabeth Lackner as Chief Scientific Officer

InflaRx Provides Development Update for Vilobelimab in Pyoderma Gangrenosum and Severe COVID-19

Galapagos übernimmt CellPoint und AboundBio

RedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22

Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer

Marinomed Biotech AG: Annual General Meeting elects Dr. Elisabeth Lackner and Ulrich Kinzel to the Supervisory Board

EsoCap holds a multidisciplinary advisory board meeting on Barrett’s esophagus

AiCuris is opening first study centers in Germany for its international pivotal phase 3 trial with pritelivir for the treatment of herpes simplex virus infections in immunocompromised patients